Omalizumab in chronic urticaria: A retrospective series of 15 cases

Dermatologic Therapy

Volumn 26, Issue 3, 2013, Pages 257-259

  Armengot Carbo, Miquel ^a   Velasco Pastor, Manuel ^a   Rodrigo Nicolas, Beatriz ^a   Pont Sanjuan, Virginia ^a   Quecedo Estebanez, Esther ^a   Gimeno Carpio, Enrique ^a  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

chronic idiopathic urticaria; omalizumab; urticaria

Indexed keywords

OMALIZUMAB;

ADULT; AGED; ARTICLE; CHRONIC URTICARIA; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HUMAN; IDIOPATHIC DISEASE; MALE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTI-ALLERGIC AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; URTICARIA;

EID: 84878802140     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2013.01549.x     Document Type: Article

References (5)

1. Saini S, Rosen KE, Hsieh HJ, et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol 2011: 128: 567-573.
2. Saavedra MC, Sur S,. Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab. Clin Mol Allergy 2011: 9: 2.
3. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009: 64: 1427-1443.
4. Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK,. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 2008: 122: 569-573.
5. Maurer M, Altrichter S, Bieber T, et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol 2011: 128: 202-209.